Flexible Ureteroscopy With a Flexible and Navigable Suction Ureteral Access Sheath Versus Mini-Percutaneous Nephrolithotomy for 1-2 cm Lower Pole Kidney Stones
FLAME
1 other identifier
interventional
640
1 country
1
Brief Summary
This study, known as the FLAME Trial (Flexible ureteroscopy for Lower pole stones And Mini-pErcutaneous nephrolithotomy), is an international, multicenter, randomized, non-inferiority trial. It aims to compare the effectiveness and safety of flexible ureteroscopy using a flexible and navigable suction ureteral access sheath (FANS) versus mini-percutaneous nephrolithotomy (mini-PCNL) in the treatment of 1-2 cm lower pole kidney stones. A total of 640 eligible adult patients will be enrolled across 20 high-volume urology centers in China, Russia, Turkey, and India. Participants will be randomly assigned to undergo either FANS-assisted flexible ureteroscopy or mini-PCNL. The primary outcome is the immediate stone-free rate (SFR) assessed by non-contrast CT within 72 hours after surgery. Secondary outcomes include SFR at 1 month, operative time, pain score, length of hospital stay, complication rates, and changes in health-related quality of life. The goal of this trial is to determine whether the less invasive FANS-assisted approach is non-inferior to mini-PCNL in terms of efficacy, while potentially offering advantages in postoperative recovery and safety.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 28, 2025
CompletedStudy Start
First participant enrolled
August 28, 2025
CompletedFirst Posted
Study publicly available on registry
September 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2026
CompletedSeptember 8, 2025
September 1, 2025
6 months
August 28, 2025
September 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Immediate Stone-Free Rate (SFR)
Stone-free status will be evaluated using non-contrast-enhanced computed tomography (NCCT) performed within 72 hours after surgery. Stone-free is defined as the absence of residual stone fragments or presence of clinically insignificant fragments ≤2 mm.
72 hours after surgery
Secondary Outcomes (6)
Final Stone-Free Rate (SFR) at 1 Month
1 month after surgery
Operative Time
Intraoperative
Postoperative Pain Level
Within 24 hours after surgery.
Length of Hospital Stay
From the day of surgery until the day of discharge, assessed up to 30 days postoperatively.
Complication Rate Within 1 Month
1 month after surgery.
- +1 more secondary outcomes
Study Arms (2)
FANS-fURS Group
EXPERIMENTALPatients assigned to this group will undergo flexible ureteroscopy with FANS (Flexible endoscopy-Assisted Negative-pressure Suction Sheath). The FANS facilitates direct stone visualization, fragmentation, suction, and removal under controlled pressure conditions.
mini-PCNL Group
ACTIVE COMPARATORPatients in this group will receive mini-percutaneous nephrolithotomy (mini-PCNL) via less than 20 Fr percutaneous tracts.
Interventions
The FANS with negative-pressure suction, enhancing intrarenal pressure control and fragment evacuation during flexible ureteroscopy.
Mini-PCNL is performed under general anesthesia with less than 20 Fr access tract, using rigid nephroscopy and stone fragmentation under direct visualization. Postoperative drainage is provided via nephrostomy or ureteral stent as per protocol.
Eligibility Criteria
You may qualify if:
- Adults aged 18-75 years;
- American Society of Anesthesiology (ASA) score 1-3;
- Lower pole renal stones-single or multiple-with a maximal diameter of 1-2 cm confirmed by CT;
- Ability to provide written informed consent and adhere to trial requirements.
You may not qualify if:
- Significant urinary tract anatomical anomalies (e.g. horseshoe kidney, ileal conduit);
- Stones located within a calyceal diverticulum;
- History of open nephrolithotomy or ureterolithomy (due to resultant intrarenal anatomical distortion);
- Absolute contraindications to either FANS-f-URS or mini-PCNL, including:
- Uncorrectable coagulopathy;
- Active, uncontrolled urinary tract infection;
- Severe cardiopulmonary disease precluding safe general anesthesia (e.g. decompensated heart failure, refractory COPD);
- Pregnancy;
- Inability to tolerate lithotomy or prone positioning;
- Inability to understand or complete trial documentation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The First Affiliated Hospital of Guangzhou Medical Universitylead
- Shengjing Hospitalcollaborator
- The Third Xiangya Hospital of Central South Universitycollaborator
- Saint Petersburg State University Hospitalcollaborator
- Fortune Urology Cliniccollaborator
- Zhongda Hospitalcollaborator
- Tongji Hospitalcollaborator
- The First Affiliated Hospital Hengyang Medical Schoolcollaborator
- First Affiliated Hospital of Ningbo Universitycollaborator
- The Sixth Affiliated Hospital of Guangzhou Medical Universitycollaborator
- The First Affiliated Hospital of Xiamen Universitycollaborator
- Dehong People's Hospitalcollaborator
- People's Hospital of Nanhai District, Foshancollaborator
- Huadu District People's Hospital of Guangzhoucollaborator
- Jiangmen Central Hospitalcollaborator
- Baoshan No.2 People's Hospitalcollaborator
- Guizhou Provincial People's Hospitalcollaborator
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicinecollaborator
- Tianjin Medical University Second Hospitalcollaborator
- Ankara Universitycollaborator
Study Sites (1)
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, 510230, China
Related Publications (2)
Skolarikos A, Geraghty R, Somani B, Tailly T, Jung H, Neisius A, Petrik A, Kamphuis GM, Davis N, Bezuidenhout C, Lardas M, Gambaro G, Sayer JA, Lombardo R, Tzelves L. European Association of Urology Guidelines on the Diagnosis and Treatment of Urolithiasis. Eur Urol. 2025 Jul;88(1):64-75. doi: 10.1016/j.eururo.2025.03.011. Epub 2025 Apr 22.
PMID: 40268592BACKGROUNDZhu W, Zhong J, Wang K, Yin G, Leung CH, Gadzhiev N, Gokce MI, Kalathia J, Gauhar V, Zhang G, Wu G, Li M, Fang L, Zeng S, Bai P, Li J, Zhao Z, Xi M, Mai X, Duan X, Jiang K, Cao J, Meng X, Liu S, Aloyan A, Yuan P, Zhu X, Huang T, Xing J, Du J, Wu W, Ma J, Zhong W, Zhao Z, Liu Y, Ng CF, de la Rosette J, Somani B, Qi S, Zeng G, Yuen SKK. Flexible ureteroscopy with a flexible and navigable suction ureteral access sheath versus mini-percutaneous nephrolithotomy for 1-2 cm lower pole renal stones: Protocol for an international, multicentre, randomized non-inferiority trial (FLAME trial). BJUI Compass. 2025 Nov 29;6(12):e70114. doi: 10.1002/bco2.70114. eCollection 2025 Dec.
PMID: 41323963DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Blinding of participants and surgeons is not feasible due to the obvious procedural differences between flexible ureteroscopy with FANS and mini-percutaneous nephrolithotomy. However, radiologists assessing postoperative CT scans will be blinded to treatment allocation. Clinical follow-up assessments will be performed by independent investigators who did not participate in the surgeries. Statistical analysis will also be conducted in a blinded manner, with group assignments concealed from the analyst until data interpretation is complete.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Vice-president
Study Record Dates
First Submitted
August 28, 2025
First Posted
September 8, 2025
Study Start
August 28, 2025
Primary Completion
February 28, 2026
Study Completion
March 31, 2026
Last Updated
September 8, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared due to institutional policy restrictions and data privacy considerations.